Biotech Showcase Application

Part of the Longevity Leaders World Congress 21-22nd April 2020

The Biotech Showcase is for emerging biotech companies and late-stage researchers seeking investment in ageing science and the diseases of ageing.

Run as part of the Longevity Leaders World Congress, it offers biotech professionals the opportunity to present their company to a board of potential investors. With the submission and talk specifications designed by our selection committee, presentations will reflect exactly what potential investors need to hear and provide valuable insight for those seeking funding.

The Biotech Showcase is suitable for companies seeking investment or looking to raise their profile among leaders in ageing science.

Monday 28th October 2019 - Applications open
Friday 13th December 2019 - Submission deadline closes
Week commencing 27th January 2020 - Successful applicants notified
Tuesday 25th February 2020 - Programme announced

Biotech and late-stage researchers are encouraged to apply if they are developing novel products within (but not exclusive to) the following fields:
·       Cell senescence
·       Mitochondria function
·       Gene therapy
·       Stem cells or regenerative medicine
·       DNA methylation and epigenetics
·       Systems biology and AI applications
·       Biomarker discovery
·       mTOR regulation
·       Protein degradation
·       Telomere function
·       Plasma proteomics
·       Metabolomics
·       Cancer
·       Cardiovascular disease
·       Alzheimer’s disease and dementia
·       Autoimmune diseases
·       Parkinson’s disease
·       Inflammation

There is no fee to apply for the Biotech Showcase. Successful applicants must pay the Showcase Registration Fee before Friday 21st February 2020 to participate. Fee includes access to the Longevity Leaders World Congress, please see Delegate Packages for more information.

This application should take no more than 10 minutes to complete.

Interested in the Life Lab Age Tech Showcase? Apply here

Question Title

* 1. Applicant information

Name

Company

Email Address

Phone Number

Question Title

* 2. Company information - what is your high concept pitch?

Question Title

* 3. Development stage

Discovery

Pre-clinical

Phase I/II

Phase III +

Question Title

* 4. Funding stage

Seed

Early stage

Growth

Late stage growth

Question Title

* 5. Please provide details on management and/or scientific advisory capacity

Question Title

* 6. Product type

Cell senescence

Gene therapy

DNA methylation and epigenetics

Biomarker discovery

Protein degradation

Plasma proteomics

Mitochondria function

Stem cells/regenerative medicine

Systems biology/AI

mTOR regulation

Telomere function

Cancer

Cardiovascular disease

Alzheimer’s disease and/or dementia

Autoimmune diseases

Parkinson’s disease

Inflammation

Other (please specify)

Question Title

* 7. Please provide details on your product including basic science, IP, regulatory pathway and wider market

Thanks for submitting your application. All applicants will be notified from 27th January 2020 about whether or not they have been selected. If you have any questions in the meantime please contact marketing@lsxleaders.com.